Gulf International Bank UK Ltd Has $1.42 Million Stock Position in Mettler-Toledo International, Inc. $MTD

Key Points

• Gulf International Bank UK Ltd reduced its stake in Mettler-Toledo International by 30.0%, now owning 1,204 shares valued at approximately $1.42 million.
• Significant investments have been made by other firms, notably GAMMA Investing LLC, which increased its position by over 131,000%, leading to ownership of 386,158 shares worth $456 million.
• Mettler-Toledo International reported a quarterly earnings per share of $10.09, surpassing the consensus estimate, while its stock currently has a price target average of $1,288.89 according to analysts.

Gulf International Bank UK Ltd lowered its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 30.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,204 shares of the medical instruments supplier's stock after selling 516 shares during the period. Gulf International Bank UK Ltd's holdings in Mettler-Toledo International were worth $1,421,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of MTD. Greenleaf Trust raised its holdings in Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after purchasing an additional 10 shares during the last quarter. Sequoia Financial Advisors LLC raised its holdings in Mettler-Toledo International by 1.8% during the 1st quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after purchasing an additional 11 shares during the last quarter. Albion Financial Group UT raised its holdings in Mettler-Toledo International by 1.5% during the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after purchasing an additional 11 shares during the last quarter. TD Private Client Wealth LLC raised its holdings in Mettler-Toledo International by 5.4% during the 1st quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock worth $253,000 after purchasing an additional 11 shares during the last quarter. Finally, Congress Asset Management Co. raised its holdings in Mettler-Toledo International by 1.8% during the 1st quarter. Congress Asset Management Co. now owns 667 shares of the medical instruments supplier's stock worth $788,000 after purchasing an additional 12 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Wells Fargo & Company upped their price target on Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the company an "equal weight" rating in a research note on Monday, May 5th. Jefferies Financial Group raised Mettler-Toledo International from an "underperform" rating to a "hold" rating and lowered their price target for the company from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Robert W. Baird upped their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and lowered their price target for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Barclays assumed coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price target for the company. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $1,288.89.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, Director Thomas P. Salice sold 1,062 shares of the stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director owned 283 shares in the company, valued at $368,154.70. This trade represents a 78.96% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the transaction, the director owned 120 shares in the company, valued at $139,191.60. The trade was a 89.85% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 2,589 shares of company stock worth $3,205,554. Insiders own 0.77% of the company's stock.

Mettler-Toledo International Price Performance

NYSE:MTD traded down $12.6150 during trading hours on Wednesday, reaching $1,309.9550. 95,569 shares of the stock were exchanged, compared to its average volume of 173,805. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,521.01. The firm has a 50 day moving average of $1,220.14 and a 200 day moving average of $1,188.83. The stock has a market cap of $26.99 billion, a PE ratio of 33.14, a PEG ratio of 3.94 and a beta of 1.34.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping analysts' consensus estimates of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the prior year, the firm posted $9.65 EPS. The business's revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.